4:22 02/09/2014 Pfizer: Prescription For A Strong Dividend Yield (PFE)
Pfizer: Prescription For A Strong Dividend Yield (PFE)
Seeking Alpha (registration) - 55 minutes ago
Pfizer (NYSE:PFE) looks like a good buy due to its (1) strong balance sheet, (2) low valuation, and (3) attractive dividend yield.

7:56 30/08/2014 AstraZeneca rises as investors bet on revival of Pfizer deal
AstraZeneca rises as investors bet on revival of Pfizer deal
Philly.com - Aug 30, 2014
According to reports July 29, 2014, Pfizer Inc.. the second-largest U.S. pharmaceutical maker, posted a 79 percent drop in second quarter profits, but beat analyst expectations.
UK Stocks Rise as AstraZeneca Gains on Pfizer Report - Businessweek
Investors Bet on Revival of AstraZeneca's Megadeal with Pfizer - Moneynews

20:41 27/08/2014 Growth Prospects Remain Strong For Pfizer
Growth Prospects Remain Strong For Pfizer
Seeking Alpha (registration) - Aug 27, 2014
The strategic changes in the structure and recent transactions have allowed the company to enhance its cash position. Solid cash position will be vital for the company to follow its strategic goals. Smoking Cessation market is showing moderate signs of ...

17:24 27/08/2014 Merck Collaborates With Pfizer Again For Its PD-1 Immunotherapy
Merck Collaborates With Pfizer Again For Its PD-1 Immunotherapy
Bidness ETC - Aug 27, 2014
Pfizer Inc. (PFE) and Merck & Co., Inc. (MRK) announced yesterday that they have partnered to conduct trials investigating the combined efficacy of the former's lung-cancer drug, Xalkori, along with the latter's experimental drug, Pembrolizumab ...
Pfizer to test Xalkori lung cancer drug with Merck immunotherapy - Reuters UK

14:18 27/08/2014 3 Reasons Pfizer Inc.'s Stock Could Fall
3 Reasons Pfizer Inc.'s Stock Could Fall
Motley Fool - Aug 27, 2014
Pfizer (NYSE: PFE ) may be the largest pharmaceutical company in the world, but size isn't everything when it comes to developing and selling drugs.

13:33 26/08/2014 Pfizer Inc. (NYSE:PFE) Unlikely to Be Successful with Second Bid for ...
Pfizer Inc. (NYSE:PFE) Unlikely to Be Successful with Second Bid for ...
BasicsMedia - Aug 26, 2014
Tomahawk, WI 08/26/2014 (Basicsmedia) - AstraZeneca plc (ADR) (NYSE:AZN) shares continue to surge in the market after news emerged that Pfizer Inc. (NYSE:PFE) may table another takeover bid with the three-month ban period that prevented the same ...
Pfizer Inc. (NYSE:PFE) Sets Pace With Palbo Even As The Hunt For Tax-Friendly ... - FinancialsTrend
Pfizer's Neutral Rating Reaffirmed at Zacks (PFE) - sleekmoney

23:08 22/08/2014 AstraZeneca now tougher target for Pfizer
AstraZeneca now tougher target for Pfizer
The News Journal - Aug 22, 2014
Pfizer Inc. isn't giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises.

16:00 19/08/2014 3 Reasons Pfizer Inc.'s Stock Could Rise
3 Reasons Pfizer Inc.'s Stock Could Rise
Motley Fool - Aug 19, 2014
Pfizer (NYSE: PFE ) , arguably the preeminent pharmaceutical company in the world, continues to pump out billions in free cash flow annually, deliver delectable gross margins, and pay out an annual dividend that puts the S&P 500 average yield of 2% to ...

15:29 15/08/2014 Pfizer: Continuing The Search For Tax Inversion
Pfizer: Continuing The Search For Tax Inversion
Bidness Etc - Aug 15, 2014
Pfizer's management in its earning call for the second quarter, mentioned that it was looking for a potential merger or acquisition deal that would allow the company to reduce its current corporate tax rate of 35% by moving its tax domicile to a ...
Investors sent on a wild ride by hostile deals - MarketWatch

18:27 12/08/2014 5 Things Pfizer Inc.'s Management Wants You to Know
5 Things Pfizer Inc.'s Management Wants You to Know
Motley Fool - Aug 12, 2014
For the quarter, Pfizer reported that revenue slipped 2%, or $200 million, to $12.77 billion. Profits were also a mixed tale with Pfizer's adjusted income dipping 6% and its adjusted EPS rising 4%. The company also lowered its full-year revenue ...
Pfizer Inc. (PFE): Trouble Ahead For The Stock - ETF Daily News
Intel Corporation (NASDAQ:INTC), Pfizer Inc. (NYSE:PFE), Microsoft Corporation ... - US Trade Media